skip to Main Content

Hope for New Pancreatic Cancer Treatment

Newsfeed image, light gray text on dark gray background

A new “breakthrough” drug approved to treat breast cancer could be used as a powerful weapon against aggressive forms of pancreatic cancer.

Australia’s Garvan Institute of Medical Research has shown in preclinical models that palbociclib effectively targets a major subtype of pancreatic cancer that affects two-thirds of all patients with the deadly disease.

Patient trials are underway and lead research author Dr Marina Pajic says it’s hoped the drug can be easily repurposed. Read more . . .

Back To Top